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Abstract
Background: Fatty acids are precursors in the synthesis of surfactant phospholipids. Recently, we showed
expression of apolipoprotein C-II (apoC-II), the essential cofactor of lipoprotein lipase (LPL), in the fetal mouse lung
and found the protein on the day of the surge of surfactant synthesis (gestation day 17.5) in secretory granule-like
structures in the distal epithelium. In the present study, we will answer the following questions: Does apoC-II
protein localization change according to the stage of lung development, thus according to the need in surfactant?
Are LPL molecules translocated to the luminal surface of capillaries? Do the sites of apoC-II and LPL gene
expression change according to the stage of lung development and to protein localization?
Results: The present study investigated whether the sites of apoC-II and LPL mRNA and protein accumulation are
regulated in the mouse lung between gestation day 15 and postnatal day 10. The major sites of apoC-II and LPL
gene expression changed over time and were found mainly in the distal epithelium at the end of gestation but
not after birth. Accumulation of apoC-II in secretory granule-like structures was not systematically observed, but
was found in the distal epithelium only at the end of gestation and soon after birth, mainly in epithelia with no or
small lumina. A noticeable increase in surfactant lipid content was measured before the end of gestation day 18,
which correlates temporally with the presence of apoC-II in secretory granules in distal epithelium with no or small
lumina but not with large lumina. LPL was detected in capillaries at all the developmental times studied.
Conclusions: This study demonstrates that apoC-II and LPL mRNAs correlate temporally and geographically with
surfactant lipid synthesis in preparation for birth and suggests that fatty acid recruitment from the circulation by
apoC-II-activated LPL is regionally modulated by apoC-II secretion. We propose a model where apoC-II is retained
in secretory granules in distal epithelial cells until the lumina reaches a minimum size, and is then secreted when
the rate of surfactant production becomes optimal.
Background
The preparation of the lung for an aerobic environment
includes the surge of surfactant synthesis, which occurs
late in pregnancy in Type II pneumocytes (PTII) in the
distal epithelium (for reviews see [1,2]). Pulmonary sur-
factant is a combination of lipids and proteins [3,4]
enabling normal respiration by preventing alveolar col-
lapse. Surfactant deficiency is the major cause of respira-
tory distress syndrome of the neonate (or hyaline
membrane disease) [5,6], a pathology occurring when
birth arises before adequate PTII cell maturation.
Fatty acids are precursor molecules in the synthesis of
surfactant phospholipids. They can be synthesized in the
lung or originate from circulating triglycerides. In the
plasma, triglycerides are mainly found in the core of
VLDL and chylomicrons, the latter carrying alimentary
lipids after secretion by the small intestine. In many tis-
sues including adipose tissue and skeletal muscle, deliv-
ery of fatty acids from triglyceride-rich lipoproteins
occurs by hydrolysis on the luminal surface of the capil-
lary endothelium. This reaction is catalyzed by lipopro-
tein lipase (LPL) [7,8] and requires apolipoprotein C-II
(apoC-II) as essential and specific cofactor [9,10].
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guinea pig, LPL mRNA was mainly found in alveolar
macrophages, while the protein was mainly localized in
capillaries [11]. This is compatible with a previous
observation in the adult rat where LPL activity was
found in lung macrophages [12]. In the human, fetal
lung explants from the second trimester of gestation
were studied [13]. LPL protein was found at the surface
of epithelial cells after stimulation of the tissue with
dexamethasone/8-Br-cAMP/isobutylmethylxanthine.
Recently, we reported expression of LPL and apoC-II
in the fetal mouse lung between gestation days (GD)
15.5 to 18.5 [14]. A sex difference in the level of apoC-
II mRNA was observed (P = 0.0195), while a significant
increase in LPL mRNA was found from GD 17.5 to 18.5
(P = 0.0003). Immunohistochemistry (IHC) revealed the
presence of apoC-II in secretory granule-like structures
in the distal epithelium, mainly near the basal mem-
brane, close to the mesenchyme, a structure that is dis-
t i n c tf r o ml a m e l l a rb o d i e s[ 1 4 ] .T h ef a c tt h a tt h ea p o C -
II protein is found at this site on the day when the
surge of surfactant synthesis occurs suggests the partici-
pation of apoC-II in this process. Many questions arise
from this work for which an answer will clarify the role
of apoC-II and LPL in surfactant synthesis. Does apoC-
II protein localization change according to the stage of
lung development, thus according to the need in surfac-
tant? Are LPL molecules translocated to the luminal
surface of capillaries? Do the sites of apoC-II and LPL
gene expression change according to the stage of lung
development and to protein localization? To answer
these questions, we have performed in situ hybridization
(ISH) and IHC of LPL and apoC-II from GD 15.5 to the
first days of alveolarization. QPCR analysis of apoC-II
and LPL mRNAs was also performed with samples from
GD 19.5 to postnatal day 10 (PN 10).
Results
mRNA and protein localization of LPL and apoC-II during
the pseudoglandular and the canalicular stages
The surge of surfactant synthesis occurs on GD 17.5 in
the mouse as indicated by the appearance of lamellar
bodies [15], an increase in surface activity in the mouse
lung homogenate [15], and by increases in the activity
of some enzymes involved in pulmonary lipid metabo-
lism [16,17]. Therefore, we have first studied samples
from pseudoglandular (GD 15.5) to late canalicular (GD
17.5) stages of lung development in order to determine
whether mRNA and/or protein localization of LPL and
apoC-II change in preparation to the surge of surfactant
synthesis.
On GD 15.5, apoC-II mRNA was found mainly in the
mesenchyme (Figure 1A-B). Positive signals were also
found in cells of some epithelia (Figure 1A-B), while the
most proximal epithelium was negative (Figure 1A). In
contrast, the apoC-II protein did not accumulate in all
the sites of apoC-II gene expression on GD 15.5 but
only in the epithelium where a diffuse signal was
observed in the cytoplasm (Figure 1H). On GD 17.5, the
apoC-II mRNA and protein co-localized. They were
found only in the distal epithelium with lumina (Figure
1D, L) and the most distal epithelium before apparition
o ft h el u m i n a( F i g u r e1 E ,K ) .I ts h o u l db en o t e dt h a t
structures corresponding to the most distal epithelium
differ between GD 15.5 and 17.5. The most distal
epithelium observed on GD 15.5 is no longer the most
distal epithelium on GD 17.5 where a more differen-
tiated epithelium is observed. The identity of cells
composing the most distal epithelium with no
lumina on GD 17.5 was confirmed by IHC using an
anti-cytokeratin 18 antibody (Figure 1N), which is a
marker of epithelial cells [18].
Recently we reported that the apoC-II protein accu-
mulated on GD 17.5 in the distal epithelium, more pre-
cisely in structures looking like secretory granules,
mainly localized near the basal membrane, close to the
mesenchyme [14]. Similar results were obtained here
(Figure 1K). Interestingly, we show here that localization
of the positive signal in the cells is different on GD 15.5
compared to GD 17.5. No positive secretory granules
were observed on GD 15.5. Accordingly, data obtained
on GD 16.5 show a transition state between results at
GD 15.5 and those at GD 17.5. As shown in Figure 1I,
both a diffuse positive signal in the cytoplasm of epithe-
lial cells and a few dots looking like secretory granules
were observed in the same tissue. Figure 1J is from
another GD 16.5 litter and shows small positive dots,
but no diffuse signal in the epithelium, which could
represent a later developmental event. No positive signal
was observed by ISH using lung materials of 6 fetuses
from 3 litters sacrificed on GD 16.5 (data not shown),
which is also compatible with a transition state.
LPL protein was found in capillary-like structures on
GD 15.5, GD 16.5, and GD 17.5 (Figure 2G-L and data
not shown). LPL mRNA was mainly found in epithelial
cells of the distal epithelium on GD 17.5 (Figure 2C-D).
This mRNA was absent of the proximal epithelium on
GD 17.5 except for a few cells that may present barely
detectable signals (Figure 2C). On GD 15.5, LPL mRNA
was mainly found in the mesenchyme and the distal
epithelium (Figure 2A) as for apoC-II mRNA. On GD
16.5, no signal was obtained by ISH for LPL using lung
tissues of 7 fetuses from 4 litters (data not shown).
In order to confirm that the LPL-positive signal corre-
sponds to capillaries and not to a-smooth muscle actin
(a-sma)-positive structures, an anti-platelet endothelial
cell adhesion molecule-1 (PECAM-1) antibody was used
on GD 17.5-lung tissue sections to stain capillaries. Results
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Page 2 of 14Figure 1 Distribution of apolipoprotein C-II mRNA and protein in the mouse fetal lung. Mouse tissue sections are from pseudoglandular
(GD 15.5, A, B, G, H), junction between pseudoglandular and canalicular (GD 16.5, I, J), or late canalicular (GD 17.5, C to F, K to N). In situ
hybridization (above the yellow line) (A to F) was performed with apoC-II anti-sense (A, B, D to F) and sense (C) probes. A change in sites of
apoC-II mRNA synthesis (positive signal, blue) according to developmental time was observed. Immunohistochemistry (below the yellow line)
(G-N) was performed using an anti-apoC-II polyclonal antibody (H to L), an anti-cytokeratin 18 monoclonal antibody (N), or goat IgG as negative
control (G, M). Positive signal (red) was found in the distal epithelium from GD 15.5 to GD 17.5, but it was found in secretory granule-like
structures during the canalicular stage, but not the pseudoglandular stage. A transition state was observed on GD 16.5 (I, J). Scale bars, 50 μm
(A, C, D, F to H, L, M), 20 μm (B, E, I to K), or 10 μm (N). A, artery; D, distal epithelium; M, mesenchyme; P, proximal epithelium; SM, smooth
muscle; V, vein.
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Page 3 of 14Figure 2 Distribution of lipoprotein lipase mRNA and protein in the mouse fetal lung. Mouse tissue sections are from pseudoglandular
(GD 15.5, A, B, G, H) or late canalicular (GD 17.5, C to F, I to L) stages. In situ hybridization (above the yellow line) (A to F) was performed with
LPL anti-sense (A, C to E) and sense (B, F) probes. The site of LPL mRNA synthesis (positive signal, blue) changed according to gestation time.
Immunohistochemistry (below the yellow line) (G-L) was performed using an anti-LPL polyclonal antibody (G, I to K) or goat IgG as negative
control (H, L). Positive signals (red) were mainly found on capillaries from GD 15.5 to 17.5. Scale bars, 50 μm (A to C, E to I, K, L) or 20 μm (D, J).
A, artery; C, capillary; D, distal epithelium; EC, endothelial cell; M, mesenchyme; P, proximal epithelium; SM, smooth muscle.
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Page 4 of 14show that staining of capillary network (Figure 3A-B) is
very similar to the positive signals identified as capillary-
like structures using an anti-LPL antibody. In contrast, the
use of an anti-a-sma antibody leads to a different staining
profile (Figure 3C-D).
ApoC-II (Figure 1F) and LPL (Figure 2E) mRNAs
were observed in smooth muscles surrounding large
arteries. LPL protein was found in smooth muscles of
arteries (Figure 2K), but signal intensities were lower
than those found in adjacent capillaries. No IHC signal
was found in smooth muscles for apoC-II (data not
shown). In most cases, it was difficult to determine
whether endothelial cells of large vessels were stained
because of the proximity to positive structures. Never-
theless, endothelial cells positive for LPL by IHC
(Figure 2I) and others negative for apoC-II by ISH and
IHC (data not shown) were also found on GD 17.5.
ApoC-II and LPL mRNA levels during the saccular stage
and the first segment of the alveolar stage
ApoC-II and LPL QPCR data were recently published for
samples from GD 15.5 to GD 18.5 [14], but not for further
developmental times. Here, QPCR analysis of these two
genes is presented between GD 19.5 and PN 10 using
male and female pools of various litters (Figure 4). Levels
of apoC-II mRNA showed more variations from sample to
sample than those of LPL mRNA. There was no statisti-
cally significant sex difference for the two genes, even
though higher values were observed for males for apoC-II
mRNA on PN 3 in four of the five analyzed litters (Figure
4A). A statistically significant difference according to
developmental time was observed only for LPL mRNA
(P = 0.0005) (Figure 4C).
mRNA and protein localization of LPL and apoC-II during
the saccular and the beginning of the alveolar stages of
lung development
Similarities were found between apoC-II and LPL
expression patterns during the perinatal period. Both
genes were expressed in the distal epithelium short time
before birth (Figures 5A and 6A), but not after birth
(Figures 5C and 6C) (delivery occurred during GD 19).
In contrast, the proximal epithelium was negative on
GD 17.5, showed a weak positive signal on GD 18.5 and
19.5 (data not shown), presented a marked increase in
intensity soon after birth (Figures 5C and 6C), and was
negative on PN 5 for both genes. Using 6 fetuses on GD
19.5 (3 males and 3 females) and 6 neonates on PN 0,
we confirmed that the switch from the distal to the
proximal epithelium correlated with birth, not with sex
(data not shown). ApoC-II and LPL mRNAs were also
found in a few scattered distal epithelial cells after birth.
In addition, positive signals by ISH were observed in
association with blood vessels before birth (Figures 5A
Figure 3 Distribution of PECAM-1 and a-sma proteins in the
mouse fetal lung. Mouse tissue sections isolated on GD 17.5 were
subjected to immunohistochemistry using anti-PECAM-1 (A, B) or
anti-a-sma (C, D) as primary antibodies. Capillaries are PECAM-1-
positive. Specific staining is clearly different between the two
antibodies and only the staining pattern obtained with the anti-
PECAM-1 corresponds to positive signals obtained with the anti-LPL
antibody in Figure 2. Scale bars, 80 μm (A, C), 20 μm (B) or 40 μm
(D). C, capillaries.
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Page 5 of 14and 6A) but not after birth (data not shown) for both
genes. On PN 5, thus at junction between sacculariza-
tion and alveolarization, apoC-II and LPL mRNA were
found in alveolar walls (Figures 5D-E and 6E-F), includ-
ing newly-formed septa (Figure 5E and data not shown).
Albeit similarities were observed in the expression
profiles of their encoding genes, apoC-II and LPL pro-
teins did not accumulate in the same structures. Inter-
estingly, apoC-II was observed in secretory granule-like
structures until soon after birth (Figure 5G and data not
shown), but positive signal had disappeared one day
later (Figure 5I). In fact, between GD 18.5 and PN 0,
apoC-II-positive secretory granules were mainly
observed in distal epithelia with no or small lumina, but
not with large lumina (Figure 5G-H and data not
shown). Such a discrepancy was less evident for apoC-II
mRNA for which some distal epithelia with large lumina
were also positive (Figure 5A). This strongly suggests
that apoC-II protein is synthesized and retained within
the epithelium in secretory granules until the lumina
reaches a certain diameter, and that it is then secreted
(Figure 7). We did not observe any sex difference or
developmental delay in our experiment in that the three
males and the three females analyzed on PN 0 presented
secretory granules, while the six other animals studied
on PN 1 did not show any secretory granule (data not
shown). In all of the experiments, neonates sacrificed on
PN 0 were killed between a few minutes and four hours
after the birth of the first neonate. The apoC-II protein
was still undetectable on PN 2 (Figure 5K), while secre-
tory granules were found in the epithelial cells of the
respiratory bronchioles on PN 3, near the basal mem-
brane, close to the mesenchyme (Figure 5L). Only a few
secretory granules were still positive on PN 5. ApoC-II-
positive capillaries, as those shown on Figure 5O, were
only observed in one third of the subjects analyzed on
PN 10. In fact, after its secretion, apoC-II protein may
be difficult to detect depending of the nature of its asso-
ciation with the tissue.
The situation was clearly different for LPL. The pro-
tein was found in capillaries from PN 0 to PN 10 for all
the analyzed neonates (Figure 6 H-K, M, and data not
shown) as well as before birth. LPL positive signals were
also found in cells of the respiratory bronchiole from
GD 19.5 to PN 3 (Figure 6G-J and data not shown), but
not on GD 18.5 and PN 5. In this epithelium, signal
intensity showed variation from cell to cell. In contrast,
no protein was detected in most proximal epithelium
(Figure 6I).
Cells localized in the alveolar space on PN 5 were
positive for apoC-II and LPL by both ISH (Figures 5E
and 6E) and IHC (data not shown) with no sex differ-
ence. Based on their localization and morphology, these
cells were most probably macrophages. ApoC-II and
Figure 4 Apolipoprotein C-II and lipoprotein lipase mRNA
levels in perinatal mouse lungs. Expression of apoC-II (A,) and
lipoprotein lipase (B, C) genes in developing lungs of male and
female mouse fetuses of several litters between GD 19.5 and PN 10.
(A and B): Each bar represents the value (± S.D.) obtained from
technical duplicate using a pool of male or female fetuses of the
indicated litter. (C): Means ± SEM of relative mRNA levels according
to developmental time (day). The values were calculated from the
results presented in B excluding the outlier values obtained for
males of litters no. 13 and 16. The values were normalized by two
housekeeping genes. For apoC-II and LPL, the mean values
respectively obtained at PN 2 and PN 0 were fixed as onefold.
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Page 6 of 14Figure 5 Distribution of apolipoprotein C-II mRNA and protein in the perinatal mouse lung. Mouse tissue sections are from saccular stage
(A, B, H, GD 19.5; C, G, PN 0; I, J, PN 1; K, PN 2; L, PN 3; D to F, M, N, PN 5) or alveolar stage (O, PN 10). In situ hybridization (above the yellow
line) (A to F) was performed with apoC-II anti-sense (A, C to E) and sense (B, F) probes. The major site of apoC-II mRNA synthesis (positive signal,
blue) changed after birth (compare A to C). Positive signals were found in newly-formed septa (D, E) and macrophages (E) on PN 5.
Immunohistochemistry (below the yellow line) (G-O) was performed using an anti-apoC-II polyclonal antibody (G to I, K to M, O) or goat IgG as
negative control (J, N). Positive signals (red) were found in secretory granule-like structures in distal epithelial cells on GD 19.5 (H) and PN0 (G)
but not in later timepoints. On PN 3, positive secretory granules were also found in epithelial cells of the respiratory bronchioles near the basal
membrane, close to the mesenchyme (L). Macrophages were positive on PN 5 and 10 while capillaries were positive on PN 10 in one third of
the analyzed subjects (O and data not shown). Scale bars, 50 μm( At oD ,F ,H ,K ,L ,M ,N )o r2 0μm (E, G, I, J, L, O). BV, blood vessel; C, capillary;
D, distal epithelium; MA, macrophage; P, proximal epithelium; RB, respiratory bronchiole; S, septa; V, vein.
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Page 7 of 14Figure 6 Distribution of lipoprotein lipase mRNA and protein in the perinatal mouse lung. Mouse tissue sections are from saccular stage
(A, B, GD 19.5; C, D, G, H, PN 0; I, PN 3; E, F, J, K, PN 5) or alveolar stage (L, M, PN 10). In situ hybridization (above the yellow line) (A to F) was
performed with LPL anti-sense (A, C, E, F) and sense (B, D) probes. The major site of LPL mRNA synthesis (positive signal, blue) changed at birth
(compare A and C). Positive signals were found in the alveolar wall and possibly in macrophages on PN 5. Immunohistochemistry (below the
yellow line) (G-M) was performed using an anti-LPL polyclonal antibody (G to K, M) or goat IgG as negative control (L). Positive signals (red)
were found in capillaries in all the analyzed developmental times, in respiratory bronchioles from GD 19.5 to PN 3 (J, K and data not shown),
and in macrophages on PN 5 and PN 10 (M and data not shown). Scale bars, 50 μm( At oE ,G ,L )o r2 0μm (F, H to K, M). BV, blood vessel;
C, capillary; D, distal epithelium; MA, macrophage; P, proximal epithelium; RB, respiratory bronchiole; V, vein.
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Page 8 of 14LPL proteins were also found in macrophages on PN 10
(Figures 5O and 6M).
Disaturated phosphatidylcholine determination
Disaturated phosphatidylcholine (DSPC) is quantitatively
the most important lipid of surfactant [19] and an
increase in lung DSPC content was observed after the
surge of surfactant synthesis [20]. Here, relative DSPC
levels were determined in lungs from Balb/C fetal mice
from GD 17.50 to 18.75 following a one hour mating
window (GD ± 0.02). A marked statistically significant
increase was observed between GD 18.50 and GD 18.75
(Figure 8).
Discussion
Surfactant is of the first importance in the distal epithe-
lium to prevent alveolar collapse. Our results show that
the LPL-related molecular machinery is regulated
Figure 7 Model of apoC-II secretion. Dotted lines separate different developmental time points and, for each time point, the presented distal
epithelial structures are co-observed in the same lung tissue sections. ApoC-II-containing secretory granules (dots) are observed in distal
epithelia with no or small lumina from GD 16.5 to PN 0, but not in the distal epithelia with a large lumina between GD 18.5 and PN 0. These
observations suggest that apoC-II secretion is delayed until apparition of the lumina. After its secretion, apoC-II can reach LPL molecules localized
on the luminal surface of capillaries to activate LPL activity and fatty acid recruitment. According to this hypothesis, it could be difficult to detect
apoC-II after its secretion because of the nature of its association with the tissue.
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Page 9 of 14temporally and geographically in the developing lung in
correlation with the need in surfactant lipid synthesis.
Major changes in sites of apoC-II and LPL mRNA are
summarized in Table 1. Changes in protein localization
were mainly observed for apoC-II and are summarized
in Table 2. Our results show that the tissue needing sur-
factant governs itself LPL and apoC-II gene expression
and apoC-II secretion during the critical period. Thus,
the LPL machinery is subjected to a complex regulation
during the canalicular and the saccular stages of lung
development. The need of lipids for surfactant synthesis
is particularly important during the period between the
surge of surfactant synthesis and birth. This can explain
why the distal epithelium of the lung contributes itself
to LPL and apoC-II synthesis, which must maximizes
fatty acid recruitment during this period. Our results are
compatible with those of Ryan et al [21] showing that
maternal loading with VLDL stimulates fetal surfactant
synthesis.
One major observation about apoC-II protein is that it
accumulated in secretory granules within several distal
epithelia from GD 17.5 to a developmental time point
soon after birth. Thus, a temporal and geographic corre-
lation exists between the appearance of lamellar bodies
as reported in the literature [15] and apoC-II accumula-
tion in secretory granules presented in Figure 1. In con-
trast to apoC-II, LPL protein was obviously secreted out
of the producing cells and accumulated in capillaries.
Accordingly, a rapid release of 10-15% of total tissue
LPL was observed following infusion of heparin into iso-
lated perfused adult rat lungs ([22] and references
therein). The presence of LPL in capillaries in the fetal
lung is compatible with its recognized function in
recruitment of fatty acids from lipoprotein-associated
Figure 8 Production of surfactant DSPC in the developing lung of Balb/C mice. Relative DSPC content (in μg inorganic phosphorus/mg dry
wt) in Balb/C fetal lungs according to developmental time (day). A one-hour mating window was used (± 0.02 day). Within the developmental
time window studied, DSPC varied significantly (P < 0.0001, one-way ANOVA) between GD 18.50 and 18.75 (P < 0.05, Tukey’s multiple
comparison test).
Table 1 Major sites of apoC-II and LPL mRNA accumulation
GD 15.5 GD 17.5 GD 18.5 GD 19.5 PN 0 PN 5
Mesenchyme CII & LPL
Distal epithelium CII & LPL CII & LPL CII & LPL CII & LPL
Respiratory bronchioles CII & LPL
Septa CII & LPL
Macrophages CII & LPL
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Page 10 of 14triglycerides [23,24]. In contrast to LPL, apoC-II was
observed in its producing cells within secretory granules.
This suggests that apoC-II secretion is controlled, but
not at all developmental time points. For example, no
secretory granule is observed on GD 15.5 indicating that
there is no apoC-II retention within the producing cells.
A transition state is observed on GD 16.5 with small
secretory granules, which must correspond to the reten-
tion of newly formed apoC-II molecules. From GD 18.5
to PN 0, distal epithelia with no or small lumina con-
taining apoC-II-positive secretory granules as well as
distal epithelia with large lumina negative for apoC-II
were observed. As explained in Figure 7, these observa-
tions suggest that apoC-II is secreted by distal epithelia
reaching a specific level of development, which stimu-
lates local LPL activity for fatty acid recruitment for sur-
factant synthesis. In contrast to LPL, apoC-II was not
reported to bind to the endothelium and consequently,
most of the apoC-II molecules secreted by the epithelia
w o u l db ew a s h e do f fo ft h es l i d ed u r i n gt h eI H Cp r o c e -
dure so that the presence of apoC-II in capillaries
could be difficult to demonstrate. The fact that apoC-II
is produced by the lung and not only provided by
plasma for activation of LPL in capillaries could be
explained by the great need for fatty acids for surfac-
tant production and, consequently, the very high
amount of LPL molecules necessitating apoC-II for
their activation.
A noticeable increase in surfactant lipid content was
observed between GD 18.50 and 18.75 (Figure 8). Know-
ing that surfactant lipids cannot be detected immedi-
ately when they start to be produced but have to
accumulate over the detection limit before an increase
be observed, our results are compatible with the litera-
ture showing the appearance of lamellar bodies on GD
17.5 [15]. Moreover, the marked increase in DSPC levels
coincides with the presence of distal epithelium with
large lumina without secretory granules, thus after the
beginning of apoC-II secretion for optimization of sur-
factant lipid production based on our model (Figure 7).
In 1998, LPL expression was found in lipofibroblasts
isolated from rat developing lungs [25]. More specifi-
cally, 20 fold and 3 fold increases in LPL mRNA levels
were observed by Northern blot analysis in isolated lipo-
fibroblasts and whole lungs, respectively, between post-
natal days -3 and +2. In our experiments, not only did
we fail to reproduce this rise at birth in whole mouse
lungs by quantitative real time PCR, but LPL mRNA
accumulation sites changed from distal to proximal
epithelium at birth with no or only a few positive signal
in the mesenchyme after birth. Furthermore, the IHC
signal we obtained for LPL was close to the background
in the mesenchyme during the perinatal period. Of
course, it is not excluded that LPL expression in lipofi-
broblasts be very low and under the limit of detection
in our assays, but obviously, our data indicate that this
cell population is not a major site of LPL mRNA and
protein accumulation. The results of Chen et al are also
incompatible with other studies reporting many years
ago that pulmonary LPL activity in growing rats peaks
one day before birth and decreases at birth [26,27]. The
decrease at birth may correspond to the switch we
observed in the site of LPL gene expression in the
mouse. In fact, the timing of LPL activity in the rats, the
temporal and cell specific regulations of LPL gene
expression we observed in the mouse and the presence
of LPL in capillaries underscore a role in recruitment of
lipids for the surge of surfactant synthesis. Such a role
has been already proposed based on the presence of
VLDL in the fetal circulation at 21 days’ gestation in the
rat when the peak in LPL activity occurs ([22] and refer-
ences therein).
LPL proteins were also found in other sites in the
developing lung as in respiratory bronchioles during sac-
cularization and in macrophages from the beginning of
alveolarization. As reported for rats, an increase in LPL
activity was observed after the first week of life following
the decrease at birth [26]. This observation is compati-
ble with the increase we observed in LPL mRNA from
PN 5 to 10 (Figure 4) and may be explained by
Table 2 Major sites of apoC-II and LPL protein accumulation
GD 15.5 GD 17.5 GD 18.5 GD 19.5 PN0 PN1 PN2 PN3 PN5 PN10
Epithelium C-II
Secretory granules-distal epithelium
- with no or small lumina C-II C-II C-II C-II
- with large lumina C-II
Secretory granules-respiratory bronchioles C-II
Respiratory bronchioles LPL LPL LPL LPL LPL
Capillaries LPL LPL LPL LPL LPL LPL LPL LPL LPL LPL (CII)*
Macrophages CII & LPL CII & LPL
Not observed C-II C-II
* ApoC-II was observed in capillaries only in one third of the analyzed subjects on PN 10
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LPL as reported here (Figure 6) and in the literature [12].
Our data cannot support or exclude LPL expression by
lipofibroblasts at this developmental time.
No sex difference was observed in sites of apoC-II and
LPL gene expression and protein accumulation for any
of the analyzed time point. No sex difference in signal
intensity was observed, although ISH and IHC are not
reliable quantitative tools. QPCR analysis (Figure 4) did
not reveal any significant sex difference when all the
population was considered, but some differences from
sample to sample prevented us to conclude at the
a b s e n c eo fa n ys e xd i f f e r e n c ea ts p e c i f i ct i m ep o i n t s ,a s
at PN 3 when higher levels of apoC-II mRNA were
observed more frequently in males. The sex difference
reported recently [14] in apoC-II mRNA levels in favor
of females in developmental times preceding GD 19.5 is
not ruled out by the present work. This statistically sig-
nificant sex difference in apoC-II mRNA suggests that a
significant proportion of females would start accumulat-
ing apoC-II earlier than males.
Hypertriglyceridemia is observed in both LPL and
apoC-II deficiencies [8], while there is no evidence that
these deficiencies may be associated with a high rate of
mortality related to respiratory distress syndrome of the
neonate in the human. The situation is different in LPL
knockout mice, which present a high rate of neonatal
death caused by respiratory problems [28]. However, the
cause of death was engorgement of capillaries by chylo-
microns leading to cyanosis, not surfactant insufficiency.
Therefore, apoC-II and LPL seem not essential for
obtaining minimal surfactant levels following birth at
term. This situation is not surprising knowing that LPL
activity is only one of the two sources of fatty acids, the
remaining source being de novo synthesis through fatty
acid synthase. As it is frequently observed for essential
mechanisms/metabolisms, a redundancy is observed
here in the source of fatty acids for surfactant synthesis.
Interestingly, in mice deficient in adipose tissue LPL, fat
mass was preserved by large increases in endogenous
fatty acid biosynthesis, which compensated for the loss
of LPL activity [8,29]. A similar situation should occur
in the developing lung of LPL- and apoC-II-deficient
subjects. In fact, the importance of the work presented
here lies in the fact that preterm birth frequently leads
to surfactant insufficiency and therefore, apoC-II/LPL
may become an interesting pharmaceutical target in that
context.
Conclusions
We have shown that sites of apoC-II as well as LPL
mRNA and protein accumulation are regulated during
the canalicular and the saccular stages of lung develop-
ment. These changes show a complex regulation of the
LPL molecular machinery during an important period
for the adaptation of the lung to gas exchange. From
this work, apoC-II appears to be an interesting potential
pharmaceutical target for treatment and/or prevention
of respiratory distress syndrome of the neonate.
Methods
Mouse tissue preparation
Protocols were approved by the Animal Care and Use
Committee and the Institutional Review Board of the
Centre de Recherche du Centre Hospitalier Universitaire
de Québec (protocols no. 2005-091 and 2008-071-2).
Except for DSPC determination, female and male Balb/c
mice (Charles River Laboratories St-Constant S.A., St-
Constant, Qc, Canada) were mated during the night
(mating window ± 8 h). The day of copulatory plug was
considered as GD 0.5 (term GD 19.5) while the begin-
ning of PN 0 corresponded to delivery. For DSPC deter-
mination, a mating window of one hour was used and
the middle of this window was considered as GD 0.00.
Pregnant females were killed by exposure to a CO2
atmosphere. The fetal sex was identified by examination
of the genital tract. Confirmation of individual sex was
done by PCR amplification of the Sry gene. Fetal lungs
were collected and either kept frozen until RNA extrac-
tion or fixed in 4% buffered paraformaldehyde for 48 h
at 4°C. Tissues were paraffin-embedded and cut in 5 μm
slices. ISH and IHC were performed on samples from
o n ef e m a l ea n do n em a l eo ft h r e eo rf o u rl i t t e r sf o r
each gestation or postnatal day studied.
RNA probes and in situ hybridization
Specific amplicons were synthesized from fetal lung
cDNA using oligonucleotides designed to span at least
one intron. Amplified gene/GenBank accession number/
position of the amplified sequence/5’ oligonucleotide/3’
oligonucleotide (sequences include one restriction site
for sub-cloning): Lpl/[GenBank:NM_008509]/750-955/
GGGGAATTC-CAGCTGGGCCTAACTTTGAG/GG
GAAGCTT-AATCACACGGATGGCTTCTC; ApoC-II/
[GenBank:NM_009695]/269-508/GGGGAATTC-CCTG
GCTCTATTCCTGGTCA/GGGAAGCTT-
AAAATGCCTGCGTAAGTGCT. These amplicons were
cloned into pGEM-4Z (Promega Corp., WI, USA). DNA
matrix for SP6 and T7 polymerases were prepared by
PCR amplification of each oft h es u b c l o n e da m p l i c o n
with the oligonucleotides GGATTTAGGTGACACTA-
TAGAATA and TAATACGACTCACTATAGGGA-
GAC, which overlap the 5’ end of the SP6 and the T7
promoters, respectively. Then, RNA probes were pre-
pared using digoxigenin (DIG)-UTP substrate (Roche
Diagnostics, Qc, Canada) and SP6 (sense) or T7 (anti-
sense) RNA polymerases (Roche Diagnostics), as pre-
viously described [30]. ISH was performed as reported
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Page 12 of 14[30] except that denatured DIG-cRNA probes were used
at 5 ng/μl. Slides were counterstained with 0.25% neu-
tral red.
Immunohistochemistry
Tissues were deparaffinized and subjected to IHC as
reported [30]. The anti-apoC-II (T-12) (1:100) and the
anti-LPL (C-20) (1:20) antibodies were purchased from
Santa Cruz Biotechnology Inc. (CA, USA). A mouse
anti-cytokeratin 18 monoclonal antibody (Abcam Inc.,
MA, USA) (1:200) was also used. A goat IgG prepara-
tion (Vector Laboratories Inc, ON, Canada) was used
instead of primary antibody as negative control. A
mouse anti-a-sma (VWR International CO., QC,
Canada) (1:200) was also used. A biotinylated donkey
anti-goat IgG (Millipore Canada Ltd, ON, Canada) and
a biotinylated goat anti-mouse IgG (Cedarlane, ON,
Canada) were used as secondary antibodies. The signals
were revealed with the streptavidin-biotin peroxidase
reaction method using an ABC Vectastain elite kit (Vec-
tor Laboratories Inc) and 3-amino-9-ethylcarbazole
(AEC, Sigma-Aldrich) as chromagen. Slides were coun-
terstained with Mayer’s hematoxylin.
Slightly different conditions were used for the rabbit
anti-PECAM-1 antibody (Abcam Inc, Cambridge, MA,
USA). After deparaffinization, the antigen retrieval step
consisted in a treatment with proteinase K (10 mg/ml in
PBS) for 20 min. Incubation with the primary (anti-
PECAM-1 antibody (1:10)) and the secondary antibodies
and all washing steps were performed in 0.1% Tween 20
in PBS.
Quantitative real-time PCR and statistical analysis
RNA extraction, cDNA synthesis, and QPCR were per-
formed as described [14]. QPCR values were normalized
for the amount of RNA input for each sample using a
set of normalization factors obtained as described
[14,31] from glyceraldehyde-3-phosphate dehydrogenase
(Gapdh) and hydroxymethylbilane synthase (Hmbs)
housekeeping genes.
Statistical analysis was performed using all data,
including the outlier values. To ensure normality and
homogeneous variances of the data set, the natural loga-
rithm and the reciprocal of the dependent variable
(expression) were used for apoC-II and LPL, respec-
tively. To study the effects of the day of gestation and
sex parameters on the expression of each gene, two-way
ANOVA with repeated measures analyses were con-
ducted using GraphPad Prism 5.01 (GraphPad Software
Inc., CA, USA). The day of gestation was considered as
a fixed factor. To account for possible correlations
between observations made from the same litter,
male and female values were considered as repeated
measures.
DSPC determination and statistical analysis
DSPC determination was performed for each fetus of
the 3 to 5 litters per time point. A small piece of frozen
lung was used to determine wet weight to dry weight
ratio. Each individual remaining fetal lung sample was
weighed. Homogenization and lipid extraction were per-
formed according to the method of Bligh and Dyer [32].
DSPC was then isolated as reported [33] using osmium
tetroxide (Sigma-Aldrich, St Louis, MO, USA) and a
column of aluminum oxide (neutral alumina, activated,
150 mesh, Sigma-Aldrich). The resulting DSPC mole-
cules were hydrolyzed to liberate phosphorus according
to the method of Bartlett [34] with slight modifications.
Briefly, 150 μl of 10N sulphuric acid was added and
samples were heated at 150°C in a Pasteur oven for
2h o u r s .T h e n5 0μl of 30% phosphorus-free hydrogen
peroxide were added before 24-hour incubation at 150°
C. The amount of phosphorus corresponded to the
amount of DSPC. Phosphorus assay was performed as
follow [34]. A standard curve was made using a phos-
phorus standard solution (1000 μg/ml of P in H2O,
Sigma-Aldrich). Fifty μl of 5% (w/v) ammonium molyb-
date and 50 μl Fiske-Subbarow reagent (15% Fiske-
Subbarow Reducer, Sigma-Aldrich) were added. Samples
were heated 20 min in a boiling water bath and the
color, directly proportional to the concentration of inor-
ganic phosphorus, was read at 825 nm in a Beckmann
DU-640 spectrophotometer.
Statistical analyses were done using values of indivi-
dual fetuses (10 to 25 individuals from 3 to 5 litters per
developmental time point). One-way ANOVA was done
to study the effect of developmental time on the amount
of DSPC, followed by Tukey’s multiple comparison test,
both using GraphPad Prism software (version 5.01 for
Windows, San Diego, CA). For all the analyses, a
P-value < 0.05 was considered significant.
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